Bio-Rad Laboratories
BIO
$236.74
Share price
2.04%
Change (1 day)
-17.79%
Change (1 year)
Categories
Bio-Rad Laboratories, Inc. is an American manufacturer of products for the life science research and clinical diagnostics markets.
Bio-Rad Laboratories (BIO) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : $2.84 Billion USD
According to Bio-Rad Laboratories's latest financial reports the company's total liabilities are $2.84 Billion USD. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Bio-Rad Laboratories - Total liabilities on balance sheet (from 2001 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.79 B | -21.45% |
| 2023-12-31 | $3.55 B | -8.45% |
| 2022-12-31 | $3.88 B | -5.54% |
| 2021-12-31 | $4.11 B | 33.03% |
| 2020-12-31 | $3.09 B | 37.22% |
| 2019-12-31 | $2.25 B | 41.68% |
| 2018-12-31 | $1.59 B | 18.47% |
| 2017-12-31 | $1.34 B | 5.62% |
| 2016-12-31 | $1.27 B | 4.28% |
| 2015-12-31 | $1.21 B | 5.46% |
| 2014-12-31 | $1.15 B | -3.82% |
| 2013-12-31 | $1.20 B | -15.82% |
| 2012-12-31 | $1.42 B | 5.59% |
| 2011-12-31 | $1.35 B | -11.16% |
| 2010-12-31 | $1.52 B | 21.14% |
| 2009-12-31 | $1.25 B | 30% |
| 2008-12-31 | $0.96 B | -3.33% |
| 2007-12-31 | $0.99 B | 28.75% |
| 2006-12-31 | $0.77 B | 1.04% |
| 2005-12-31 | $0.76 B | -0.79% |
| 2004-12-31 | $0.77 B | 55.95% |
| 2003-12-31 | $0.49 B | 47.15% |
| 2002-12-31 | $0.33 B | -15.63% |
| 2001-12-31 | $0.40 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 PerkinElmer
PKI | $6.60 B | 131.93% | 🇺🇸 USA |
 Thermo Fisher Scientific TMO | $49.55 B | 1,640.33% | 🇺🇸 USA |
 Becton Dickinson BDX | $29.22 B | 926.37% | 🇺🇸 USA |
 Agilent Technologies A | $6.02 B | 111.48% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $115.56 B | 3,958.37% | 🇺🇸 USA |
 Danaher DHR | $28.25 B | 892.41% | 🇺🇸 USA |
 General Electric GE | $104.65 B | 3,575.33% | 🇺🇸 USA |